Impact of Neoadjuvant Chemotherapy With Gemcitabine Plus Nab-paclitaxel on the Treatment for Borderline Resectable Pancreatic Cancer

被引：0
|
作者：
Miyasaka, Y. [1 ,2 ]
Ohtsuka, T. [1 ]
Kimura, R. [1 ]
Mori, Y. [1 ]
Nakata, K. [1 ]
Nakamura, M. [1 ]
机构：
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka, Japan
[2] Fukuoka Univ, Dept Surg, Chikushi Hosp, Chikushino, Japan
来源：
PANCREAS | 2019年 / 48卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1492 / 1492
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant gemcitabine and nab-paclitaxel followed by concurrent capecitabine and radiation efficacy in borderline resectable (BR) pancreatic cancer.
    Gupta, Niraj K.
    Singh, Kirpal
    Glass, Timothy
    Davis, Chad
    Lybik, Mark
    Leagre, Christopher
    Liebross, Robert H.
    Dugan, Thomas
    Edwards, Mark
    Givens, Stanley
    Compton, Julia
    Tigges, Thomas
    Flanders, Vincent
    Mathavan, Vinay
    Isch, Andrew
    Reeves, Dave
    Arevalo, Gabriel
    Rowe, Michael
    Kaderabek, Douglas
    Arregui, Maurice
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Cost-effectiveness of neoadjuvant FOLFIRINOX versus gemcitabine plus nab-paclitaxel in locally advanced/borderline resectable pancreatic cancer patients.
    Ingram, Myles
    Lauren, Brianna N.
    Pumpalova, Yoanna S.
    Manji, Gulam Abbas
    Bates, Susan Elaine
    Hur, Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] Maintenance treatment with gemcitabine after gemcitabine plus Nab-paclitaxel in advanced pancreatic cancer
    Kodama, Tomoko
    Nakazawa, Junichi
    Kawahira, Masahiro
    Ymasuji, Akihiro
    Iwashita, Yuji
    Hori, Takeshi
    Kawahira, Machiko
    Arima, Shiho
    Tubouchi, Hirohito
    Ido, Akio
    ANNALS OF ONCOLOGY, 2022, 33 : S484 - S484
  • [24] Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer-A Systematic Review and Meta-Analysis
    Damm, Marko
    Efremov, Ljupcho
    Birnbach, Benedikt
    Terrero, Gretel
    Kleeff, Jorg
    Mikolajczyk, Rafael
    Rosendahl, Jonas
    Michl, Patrick
    Krug, Sebastian
    CANCERS, 2021, 13 (17)
  • [25] Efficacy and safety of neoadjuvant Folfirinox and Gemcitabine plus Nab-Paclitaxel for borderline resectable and locally advanced pancreatic cancer: a systematic review and meta-analysis
    Dong, L. -p.
    Liu, Y. -m.
    Lu, W. -j.
    Tang, K. -z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (17) : 6316 - 6327
  • [26] Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel Regimen for Borderline Resectable Pancreatic Cancer with Arterial Involvement: A Prospective Multicenter Single-Arm Phase II Study Protocol
    Miyasaka, Yoshihiro
    Ohtsuka, Takao
    Eguchi, Susumu
    Inomata, Masafumi
    Nishihara, Kazuyoshi
    Shinchi, Hiroyuki
    Okuda, Koji
    Baba, Hideo
    Nagano, Hiroaki
    Ueki, Toshiharu
    Noshiro, Hirokazu
    Nakamura, Masafumi
    INTERNATIONAL JOURNAL OF SURGERY PROTOCOLS, 2021, 25 (01): : 55 - 60
  • [27] A phase II study of gemcitabine/nab-paclitaxel/S-1 combination neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer with arterial contact
    Kondo, Naru
    Uemura, Kenichiro
    Sudo, Takeshi
    Hashimoto, Yasushi
    Sumiyoshi, Tatsuaki
    Okada, Kenjiro
    Seo, Shingo
    Otsuka, Hiroyuki
    Murakami, Yoshiaki
    Takahashi, Shinya
    EUROPEAN JOURNAL OF CANCER, 2021, 159 : 215 - 223
  • [28] Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
    Von Hoff, Daniel D.
    Ervin, Thomas
    Arena, Francis P.
    Chiorean, E. Gabriela
    Infante, Jeffrey
    Moore, Malcolm
    Seay, Thomas
    Tjulandin, Sergei A.
    Ma, Wen Wee
    Saleh, Mansoor N.
    Harris, Marion
    Reni, Michele
    Dowden, Scot
    Laheru, Daniel
    Bahary, Nathan
    Ramanathan, Ramesh K.
    Tabernero, Josep
    Hidalgo, Manuel
    Goldstein, David
    Van Cutsem, Eric
    Wei, Xinyu
    Iglesias, Jose
    Renschler, Markus F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (18): : 1691 - 1703
  • [29] Preoperative treatment with gemcitabine plus nab-paclitaxel is a safe and effective chemotherapy for pancreatic adenocarcinoma
    Ielpo, B.
    Duran, H.
    Diaz, E.
    Fabra, I.
    Caruso, R.
    Fern, V.
    Malave, L.
    Hidalgo, M.
    Alvarez, R.
    Plaza, C.
    Quijano, Y.
    Vicente, E.
    EJSO, 2016, 42 (09): : 1394 - 1400
  • [30] Nab-paclitaxel plus gemcitabine in the treatment of metastatic pancreatic cancer: our experience
    Mare, M.
    Munao, S.
    Germana, S.
    Colarossi, C.
    Sciacca, D.
    Giuffrida, D.
    Giannone, G.
    ANNALS OF ONCOLOGY, 2017, 28
12345